A detailed history of Aa Financial Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Aa Financial Advisors, LLC holds 4,607 shares of LLY stock, worth $3.67 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares
4,607
Previous 4,289 7.41%
Holding current value
$3.67 Million
Previous $3.88 Billion 5.1%
% of portfolio
1.18%
Previous 1.37%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$772.14 - $960.02 $245,540 - $305,286
318 Added 7.41%
4,607 $4.08 Billion
Q2 2024

Jul 16, 2024

SELL
$724.87 - $909.04 $162,370 - $203,624
-224 Reduced 4.96%
4,289 $3.88 Billion
Q1 2024

May 03, 2024

BUY
$592.2 - $792.28 $2.3 Million - $3.07 Million
3,879 Added 611.83%
4,513 $3.51 Billion
Q4 2023

Apr 02, 2024

BUY
$525.19 - $619.13 $332,970 - $392,528
634 New
634 $370 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $758B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Aa Financial Advisors, LLC Portfolio

Follow Aa Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aa Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aa Financial Advisors, LLC with notifications on news.